So sánh phương pháp

	Thử nghiệm lâm sàng Giai đoạn II được khớp cặp	Nghiên cứu bệnh-chứng bắt cặp
Lĩnh vực	Dịch tễ học	Dịch tễ học
Họ	Process / pipeline	Process / pipeline
Năm ra đời	1960s–1980s (formalized with Simon optimal designs, 1989)	1950s–1970s
Người khởi xướng	Gehan (1961) for Phase II designs; matching frameworks adapted from case-control methodology	Brian MacMahon and others; systematised by Schlesselman (1982)
Loại	Controlled clinical trial design	Observational analytic design
Công trình gốc	Gehan, E. A. (1961). The determination of the number of patients required in a preliminary and a follow-up trial of a new chemotherapeutic agent. Journal of Chronic Diseases, 13(4), 346–353.	Rothman, K. J., Greenland, S., & Lash, T. L. (2008). Modern Epidemiology (3rd ed.). Lippincott Williams & Wilkins. ISBN: 978-0781755474
Tên gọi khác	matched Phase II trial, historically matched Phase II study, propensity-matched Phase II trial, externally controlled Phase II trial	matched case-referent study, individually matched case-control, pair-matched case-control, matched case-control design
Liên quan	5	5
Tóm tắt	A matched Phase II clinical trial is a single-arm or small-controlled early-efficacy study in which treated patients are paired with matched controls — drawn from historical databases, registries, or concurrent external cohorts — on key prognostic variables such as age, disease stage, and performance status. This design allows preliminary efficacy assessment without a concurrent randomized arm, trading randomization for feasibility while partially controlling for confounding through the matching process.	A matched case-control study is an observational epidemiological design in which each case (a person with the disease or outcome of interest) is paired with one or more controls (persons without the outcome) who share one or more characteristics — such as age, sex, or clinical setting — to control confounding. Exposure history is then compared between cases and their matched controls to estimate the odds ratio of the exposure-disease association.